Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target is a pseudogene associated with the regulatory subunit B56 gamma isoform of protein phosphatase 2A (PP2A). PP2A is a major serine/threonine phosphatase involved in cell cycle regulation, cell signaling, and tumor suppression. However, the described gene does not encode a functional protein but is a nonfunctional copy related to PPP2R5C, located at chromosome 3p21.3 (PPP2R5CP), in contrast to the functional PPP2R5C gene at chromosome 14q32.2. As such, it is not a therapeutic target, does not have known interacting drugs, disease roles, or established biological functions, and serves primarily as a genomic relic.
None; no mechanisms of action for drugs because it is not expressed as a functional protein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 2, regulatory subunit B', gamma isoform pseudogene (PPP2R5CP).